It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

With cell manufacturing constrained, investments in storage systems are accelerating. Reliance Industries has put on hold plans to manufacture lithium-ion battery cells in India after failing to ...

As the U.S. solar PV sector scales up domestic cell manufacturing, long-term competitiveness will depend on whether American ...

Despite the perception of biopharma as a field that is slow to adopt new technology, artificial intelligence (AI) has been quietly improving the sector for years, from candidate prioritization in drug ...

Mesenchymal stem/stromal cells (MSCs) have been identified as a promising resource for cell therapies due to their high immunomodulation ability, anti-inflammatory properties, tissue regeneration ...